Kymera Therapeutics, Inc. (KYMR)
83.10
+4.87
(+6.23%)
USD |
NASDAQ |
Jun 11, 16:00
83.10
0.00 (0.00%)
After-Hours: 19:52
Kymera Therapeutics Accounts Payable (Quarterly) : 12.84M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 12.84M |
| December 31, 2025 | 4.015M |
| September 30, 2025 | 5.506M |
| June 30, 2025 | 5.781M |
| March 31, 2025 | 10.26M |
| December 31, 2024 | 5.989M |
| September 30, 2024 | 6.494M |
| June 30, 2024 | 6.51M |
| March 31, 2024 | 6.812M |
| December 31, 2023 | 7.075M |
| September 30, 2023 | 4.978M |
| June 30, 2023 | 3.745M |
| March 31, 2023 | 6.483M |
| Date | Value |
|---|---|
| December 31, 2022 | 4.335M |
| September 30, 2022 | 6.327M |
| June 30, 2022 | 2.374M |
| March 31, 2022 | 2.567M |
| December 31, 2021 | 4.005M |
| September 30, 2021 | 5.033M |
| June 30, 2021 | 8.177M |
| March 31, 2021 | 8.348M |
| December 31, 2020 | 4.368M |
| September 30, 2020 | 3.979M |
| June 30, 2020 | 3.982M |
| March 31, 2020 | |
| December 31, 2019 | 3.276M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 80.54M |
| Erasca, Inc. | 2.163M |
| Arrowhead Pharmaceuticals, Inc. | 30.75M |
| Sarepta Therapeutics, Inc. | 70.38M |
| Vir Biotechnology, Inc. | 5.445M |